Cell Surface Marker Detection Market Expected To Trigger A Revenue Increase To USD 6.49 Billion By 2022:Key Participant MSiemens Healthcare, Nihon Kohden Corporation

San Francisco, 06 December 2018, The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 

Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 

Access Full Research Report On Cell Surface Marker Detection Market Analysis:
www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market

Further key findings from the report suggest:

·         Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 

·         Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 

·         Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 

·         North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 

·         North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 

·         Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 

·         Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 

·         These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions 

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented cell surface marker detection market on the basis of product, application, and region:

Cell Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022 )

·         Flow Cytometry

·         Hematology Analyzers

·         Reagents & Kits

Cell Surface Marker Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022 )

·         Disease Diagnosis & Identification

·         Research & Drug Discovery

·         Others

Cell Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )

·         North America

·         Europe

·         Asia Pacific

·         RoW

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Mammography Market Expected To Trigger A Revenue Increase To 3.8 Billion By 2025:Key Participant Phillips Healthcare, Siemens Healthcare

San Francisco, 01 November 2018 , The global mammography market is expected to reach a value of USD 3.8 billion by 2025, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of microcalcifications in breast tissue. Some significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting the early diagnosis of mammary gland calcification, which is one of the crucial factors expected to drive the demand over the forecast period.

Based on a report published by the National Cancer Institute in 2015, it was stated that the proportion of women aged 45 to 65 years had increased to 81.1% in breast cancer screening. Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years.

In January 2016, FDA approved a new manual for digital mammography quality control by the American College of Radiology. The growing number of awareness campaigns to promote womens’ health services is also anticipated to propel growth.

Some of the key industry players are Fujifilm; Hologic; Philips Healthcare; Siemens Healthineers; Toshiba Medical Systems Corporation; GE Healthcare; Metaltronica; PLANMED OY; Mindray Medical International Limited; and IMS srl.

Full Research Report On Mammography Market Analysis:
www.grandviewresearch.com/industry-analysis/mammography-market

Further Key Findings From the Study Suggest:

·         Digital systems dominated the product segment in 2015 owing to the wide availability of digital breast screening devices and presence of favorable reimbursements for such devices

·         Digital mammography dominated the application segment in 2015 due to growing awareness regarding digital technology and increasing adoption of such technology for better diagnosis

·         In 2015, North America dominated due to the increasing adoption of technologically advanced screening devices and up surging number of approvals of 3D systems

·         Asia Pacific and Latin America are the two fastest growing regional segments, because of the higher mammary gland cancer prevalence and growing number of government campaigns to improve screening results

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the mammography market by product, technology, and region: 

Product Outlook (Market Revenue in USD Million, 2013 - 2025)

·         Film Screen Systems

·         Digital Systems

·         Analog Systems

·         Biopsy Systems

·         3D Systems

Technology Outlook (Market Revenue in USD Million, 2013 - 2025)

·         Breast Tomosynthesis

·         CAD

·         Digital

Regional Outlook (Market Revenue in USD Million, 2013 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         Middle East and Africa

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-mammography-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Breast Imaging Market Expected To Trigger A Revenue Increase To USD 7.3 Billion By 2024:Key Participant Dilon Technologies, Inc., Hologic, Inc.

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of breast cancer and supportive government initiatives to increase awareness are expected to boost demand in the market.

Supportive government initiatives such UK government campaign’s “Be clear on cancer,” which helped in spreading awareness about the risk factors, preventive measures, and early diagnosis of cancer. This campaign also included free screening programs, which helped in diagnosing around 15,000 cancer patients.

Technological advancements in the imaging sector are expected to boost growth in the market. Companies such as Gamma Medica, Dilon Technologies, and SonoCine are completely dedicated to developing improved technologies in the field of breast imaging. The innovation of complimentary products such as the breast pad designed by GE Healthcare to provide comfort to a woman undergoing screening is expected to catalyze the market growth further.

Full Research Report On Breast Imaging Market Analysis:www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the report suggest:

·         The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.

·         North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, promotes the development of personalized medicine, which is anticipated to foster market growth.

·         Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.

·         Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.

Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global breast imaging market on the basis of technology and region:

Breast Imaging Technology Outlook (Revenue, USD Million; 2013 - 2024)

·         Ionizing

o    Full-Field Digital Mammography

o    Analog Mammography

o    Positron Emission Mammography

o    Electric Impedance Tomography

o    Cone-Beam Computed Tomography

o    Positron Emission Tomography & Computed Tomography

o    3D Breast Tomosynthesis

o    MBI/BSGI

·         Non Ionizing

o    MRI

o    Thermography

o    Ultrasound

o    Optical Imaging

o    Automated Whole-Breast Ultrasound

Breast Imaging Regional Outlook (Revenue, USD Million; 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-breast-imaging-equipment

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Coagulation Analyzers Market To Surpass 7.9 Billion By 2024 | Key Industry Players Roche Diagnostics

Coagulation Analyzer market by region, 2015 & 2024

The global Coagulation Analyzers/Reagents Market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

·         Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances

·         Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity

·         Automatic reflex testing, repeat testing, and redilution

Full Research Report On Coagulation Analyzers/Reagents Market Analysis:

www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market

Further key findings from the study suggest:

·         Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.

·         Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.

·         Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.

·         Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.

·         The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.

·         Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.

·         For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region.

Product Outlook (Revenue, USD Million, 2013 - 2024)

·         Analyzers

o    Clinical Laboratory Analyzers

o    Point of Care Analyzers   

·         Consumables

o    Reagents

o    Stains

Technology Outlook (Revenue, USD Million, 2013 - 2024)

·         Mechanical

·         Electrochemical

·         Optical

o    Photo optical/Chromogenic/Immuno

o    Others/Nephelometric

·         Others

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

·         APTT

·         D-Dimer

·         Fibrinogen

·         Prothrombin

·         Others

End-Use Outlook (Revenue, USD Million, 2013 - 2024)

·         Hospitals

·         Research Institutes

·         Diagnostic Centers

·         Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-coagulation-analyzers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com